IL-2 fusion protein (University of Miami Miller School of Medicine)

N/A

Report date: 2025/03/20 16:02:43

Base Information

Drug NameIL-2 fusion protein (University of Miami Miller School of Medicine)
Drug Alias NameIL-2 fusion protein (Bristol-Myers Squibb)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-2 modulators
TargetsInterleukin-2
Therapy Area/IndicationsDiabetes Mellitus, Type 1Inflammatory Bowel DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Miami Miller School of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb Company
Inactive CompaniesUniversity of Miami Miller School of Medicine
Active IndicationsDiabetes Mellitus, Type 1Inflammatory Bowel DiseasesArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A